Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• 1. Classification of MOFs by Structure: For Biomedical Engineering2. Nomenclature of MOFs3. Secondary Building Units of MOFs4. Mixed Metal Systems for the Synthesis of MOFs5. MOFs Linkers useful for Biomedical Applications6. The Role of Flexibility in MOFs7. Defects and Disorders in MOFs8. Surface Modification of MOFs for Biomedical Applications9. Hydrothermal Synthesis of MOFs10. Microwave Synthesis of MOFs11. Electrochemical Synthesis of MOFs12. Mechanochemical Synthesis of MOFs13. Sonochemical Synthesis of MOFs14. Synthetic Post-Modification of MOFs for Biomedical Applications15. Characterization of MOFs16. Adsorption, Delivery and Controlled Release of Therapeutic Molecules from MOFs17. BioMOFs18. Antibacterial Activity of MOFs19. Toxicity of MOFs in Biological Systems20. Functional MOFs as Theranostics21. Functional MOFs as Molecular Imaging Probes22. State-of-the-art and future perspectives of MOFs in medicine

Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• 1. Classification of MOFs by Structure: For Biomedical Engineering2. Nomenclature of MOFs3. Secondary Building Units of MOFs4. Mixed Metal Systems for the Synthesis of MOFs5. MOFs Linkers useful for Biomedical Applications6. The Role of Flexibility in MOFs7. Defects and Disorders in MOFs8. Surface Modification of MOFs for Biomedical Applications9. Hydrothermal Synthesis of MOFs10. Microwave Synthesis of MOFs11. Electrochemical Synthesis of MOFs12. Mechanochemical Synthesis of MOFs13. Sonochemical Synthesis of MOFs14. Synthetic Post-Modification of MOFs for Biomedical Applications15. Characterization of MOFs16. Adsorption, Delivery and Controlled Release of Therapeutic Molecules from MOFs17. BioMOFs18. Antibacterial Activity of MOFs19. Toxicity of MOFs in Biological Systems20. Functional MOFs as Theranostics21. Functional MOFs as Molecular Imaging Probes22. State-of-the-art and future perspectives of MOFs in medicine

Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute, Mount Sinai Health Hospital, University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab, at the Nanotechnology and Advanced Materials Department, Materials and Energy Research Center, Cellular and Molecular Research Center, and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS), Tehran, Iran. Dr. Mozafari’s research interests range across biomaterials, nanotechnology, and tissue engineering, and he is known for the development of strategies for the treatment of damaged tissues and organs, and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards, including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO), in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

• 1. Classification of MOFs by Structure: For Biomedical Engineering2. Nomenclature of MOFs3. Secondary Building Units of MOFs4. Mixed Metal Systems for the Synthesis of MOFs5. MOFs Linkers useful for Biomedical Applications6. The Role of Flexibility in MOFs7. Defects and Disorders in MOFs8. Surface Modification of MOFs for Biomedical Applications9. Hydrothermal Synthesis of MOFs10. Microwave Synthesis of MOFs11. Electrochemical Synthesis of MOFs12. Mechanochemical Synthesis of MOFs13. Sonochemical Synthesis of MOFs14. Synthetic Post-Modification of MOFs for Biomedical Applications15. Characterization of MOFs16. Adsorption, Delivery and Controlled Release of Therapeutic Molecules from MOFs17. BioMOFs18. Antibacterial Activity of MOFs19. Toxicity of MOFs in Biological Systems20. Functional MOFs as Theranostics21. Functional MOFs as Molecular Imaging Probes22. State-of-the-art and future perspectives of MOFs in medicine